| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8780801 | Gynecologic Oncology | 2017 | 6 Pages |
Abstract
Our findings suggest that increased NOTCH2 via loss of miR-181c is a significant component of EEA recurrence. This presents an opportunity to develop miR-181c and NOTCH2 as markers for early identification of high risk cases and the use of NOTCH inhibitors in the prevention or treatment of recurrent disease.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Eric J. Devor, Jeffrey Miecznikowski, Brandon M. Schickling, Jesus Gonzalez-Bosquet, Heather A. Lankes, Premal Thaker, Peter A. Argenta, Michael L. Pearl, Susan L. Zweizig, Robert S. Mannel, Amy Brown, Nilsa C. Ramirez, Olga B. Ioffe, Kay J. Park,